Early Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Clinical Data

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-28
SponsorKonya City Hospital

About this trial

Early Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Clinical Data from the First Three Postnatal Weeks with Large Language Models: A Retrospective Study This retrospective, observational study aims to evaluate the early prediction of bronchopulmonary dysplasia (BPD) in preterm infants using clinical data from the first, second, and third postnatal weeks. The study includes infants born before 32 weeks of gestation or weighing less than 1,500 grams, followed at the Neonatal Intensive Care Unit of Konya City Hospital.

The study will compare the performance of different large language models (LLMs), including ChatGPT, Gemini, and Claude, in predicting BPD development. Clinical variables such as gestational age, birth weight, respiratory support, oxygen requirement, mechanical ventilation duration, and infection status will be used.

Primary outcome: Accuracy of BPD risk prediction by each AI model compared to actual clinical outcomes. Secondary outcomes: Sensitivity and specificity of predictions, weekly prediction performance, and comparative performance among AI models.

The results will provide insight into the potential clinical utility of AI-based approaches for early BPD risk assessment in preterm infants.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Preterm infants born before 32 weeks of gestation or with birth weight <1,500 grams

Admitted and followed in the Neonatal Intensive Care Unit (NICU) of Konya City Hospital

Availability of complete clinical data in hospital records

Documented bronchopulmonary dysplasia (BPD) outcome status

Disqualifiers

Presence of major congenital anomalies

Incomplete or missing clinical data

Death shortly after birth with insufficient follow-up data to determine BPD status

Trial population

A retrospective cohort of preterm infants (\<32 weeks gestation or \<1,500 g) admitted to the NICU of Konya City Hospital. Only infants with complete clinical data and documented BPD status are included. Both sexes are included.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Artificial Intelligence-Based Risk Prediction

    Other intervention

    Different large language models (ChatGPT, Gemini, Claude) will analyze retrospective clinical data to predict the risk of bronchopulmonary dysplasia (BPD). This is an observational evaluation; no experimental treatment or therapy is administered.

Treatment groups

108 Participants
are divided into 1 treatment group
Group A: Preterm Infants Cohort (<32 weeks or <1500 g)1 intervention

Trial outcomes

Primary outcomes

1

Accuracy of bronchopulmonary dysplasia (BPD) risk prediction by artificial intelligence (AI) models in preterm infants.

The primary outcome is the accuracy of different large language models (ChatGPT, Gemini, Claude) in predicting BPD development. AI-generated risk predictions will be compared to actual clinical outcomes to assess prediction correctness.

Time frame
Postnatal weeks 1, 2, and 3

Secondary outcomes

1

Sensitivity and specificity of AI predictions

Evaluate the true positive rate (sensitivity) and true negative rate (specificity) of each AI model's BPD risk predictions compared to actual outcomes.

Time frame
Postnatal weeks 1, 2, and 3
2

Comparison of prediction accuracy across postnatal weeks

Compare AI model performance at different postnatal weeks to determine if prediction accuracy improves as more clinical data becomes available.

Time frame
Postnatal weeks 1, 2, and 3
3

Comparative performance of different AI models

Compare AI model performance at different postnatal weeks to determine if prediction accuracy improves as more clinical data becomes available.

Time frame
Postnatal weeks 1, 2, and 3

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: